undamentalytics Newsletter
Sign in

Exelixis, Inc. balance sheet

At the end of fiscal 2025, Exelixis, Inc. had total assets of $2.84bn, total liabilities of $683m and shareholders' equity of $2.16bn. It held $482m in cash against $0 of debt: net cash of $482m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Jan 20162016Dec 20162017Dec 20172018Dec 20182019Jan 20202020Jan 20212021Dec 20212022Dec 20222023Dec 20232024Jan 20252025Jan 2026LTMOct 2026
Cash and equivalents87977417010480142152188315267319647501263217482305
Receivables———34554012163119161283215237265287328
Inventory———032337101321273317222230
Total current assets—1832294332671671794694858971,0111,4451,8351,6191,3181,4681,4431,322
Goodwill—6464646464646464646464646464646464
Total assets—3613937215033233325966551,4221,8862,1372,6163,0712,9422,9482,8442,513
Accounts payable—224966710111224243334383031
Deferred revenue (current)—1004216130208002875311
Total current liabilities—20092828817052269115105143205338324394404406412
Short-term debt—3851312980189——————————
Long-term debt—17117732333525941800—————————
Total debt02171863393493574181890000000000
Total liabilities—589303476483483473506370135200258406583678703683680
Shareholders' equity−164−2289123814−159−141892851,2871,6861,8792,2112,4882,2642,2442,1611,834
Net debt (negative = net cash)−8712011216924527727637−188−315−267−319−647−501−263−217−482−305
Shares outstanding—109m136m184m185m196m228m290m296m300m305m312m319m324m303m282m262m245m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: EXEL vs NTRAEXEL vs MRNAEXEL vs UTHR

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Exelixis, Inc.'s SEC filings (10-K and 10-Q), retrieved October 30, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Exelixis, Inc.